Hessington Health Weight Management Service.
Obesity affects approximately 1 in 4 people in the UK and it responsible for a number of serious health problems such as, type 2 diabetes, heart disease, high blood pressure, strokes, kidney disease and an increased risk of a variety of cancers. The Body mass index (BMI) is a calculation of a patient’s body weight in kilos divided by the square of their height in meters. National Institute for Health and Care Excellence (NICE) defines a normal* BMI is in the range of 18.5 kg/m2 to 24.9 kg/m2. NICE defines several classifications of obesity:
- Overweight: BMI 25 kg/m2 to 29.9 kg/m2
- Obesity class 1: BMI 30 kg/m2 to 34.9 kg/m2
- Obesity class 2: BMI 35 kg/m2 to 39.9 kg/m2
- Obesity class 3: BMI 40 kg/m2 or more.
*The thresholds are lower for ethnic minorities
At Hessington Health we are proud to introduce our bespoke weight management service. We have a rich understanding about the underpinnings of mental and physical wellbeing through the Masters research project carried out at Wolfson College, University of Cambridge by CEO Dr Harjeev Rai. This research has allowed us to better understand the difficulties experienced by our patients who struggle to manage their weight. We will be using our knowledge to best guide you through your weight loss journey.
The weight criteria for treatment will be for those patients with the following criteria:
- BMI >27 with specific health problems
- BMI >30 irrespective of health status
- BMI >27 for ethnic minorities with or without any chronic health problems
When you enrol into our weight management service you will complete a comprehensive health survey which will explore your medical history, your previous attempts at weight loss, current body mass index and a suitability assessment for Liraglutide (in the form Saxenda) which comes from a family of drugs called the GLP-1 receptor agonists. This class of medication as an injectable treatment slows gastric emptying making you feel full resulting in reduced food intake. It also has positive effects on stimulating glucose-dependent insulin release, improving insulin resistance. Should you be a suitable candidate for injectable weight management medication in the form of Saxenda you will be invited to see us in clinic (locations – Harley Street, Elstree, and Warwickshire). Dr Rai will carry out a comprehensive physical assessment together with a set of blood tests which will allow us to benchmark your health status before starting treatment. Once we are happy to recommend Saxenda we will arrange for you to receive a starter pack of 3 injections together with a Saxenda Journal which will allow you to document your goals, periodic weight recordings and overall patient journey. You will be supported by Dr Rai throughout your treatment journey of 12 weeks. As part of our support service, you will be provided with a weblink which will allow you to access our unique patient experience and weight measurement webform. We will be monitoring your webform feedback very closely and your treatment is further supported with face-to face assessments at 4, 8 and 12 weeks of the treatment cycle.
